Model systems to assess the destructive potential of human neutrophils and monocyte-derived macrophages during the acute and chronic phases of inflammation.
about
Towards a Biocompatible, Biodegradable Copolymer Incorporating Electroactive Oligothiophene UnitsIntramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathyControlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold.Biodegradation and biocompatibility of a degradable chitosan vascular prosthesisInfection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80+ Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen.Macrophage differentiation and polarization on a decellularized pericardial biomaterialIn vitro antioxidative and anti-inflammatory effects of the compound K-rich fraction BIOGF1K, prepared from Panax ginseng.Characterization of the degradation mechanisms of lysine-derived aliphatic poly(ester urethane) scaffolds.Biodegradation of polycarbonate-based polyurethanes by the human monocytes-derived macrophage and U937 cell systems.Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitro.The effect of oxidation on the enzyme-catalyzed hydrolytic biodegradation of poly(urethane)s.Salivary esterase activity and its association with the biodegradation of dental composites.Effect of phorbol esters on the macrophage-mediated biodegradation of polyurethanes via protein kinase C activation and other pathways.Monocyte activation on polyelectrolyte multilayers.Polycarbonate-urethane hard segment type influences esterase substrate specificity for human-macrophage-mediated biodegradation.
P2860
Q30485752-099B0F2D-FD9E-4940-BA57-64AFA95AB33DQ30596582-5CA989B5-D748-4CBB-B3F6-1A40595D0215Q35432628-8A669FC4-5024-438E-9DE6-CDEB117B2456Q35660703-F8AC1D91-90D0-44AC-86E9-F1783C0F9143Q35661763-C6C0FDE5-8FE7-4EED-B058-5CCBF252ACA1Q36598477-B0609FD7-6548-4E66-AC4A-D0BB8D4031DCQ38998741-0BB5F10C-B00D-4DBA-A094-523D78445152Q39652239-12E9581E-ADE4-415A-9B59-EF7B98BE2A92Q40717289-448522BB-0741-4F94-8C63-EEDC5C15A9B5Q44060493-79B91EEB-703F-49CF-A09D-34D7F394D53BQ44104973-871E3BBA-BB36-4888-B3C4-660694C99EB8Q44703219-A6CC3BDE-7BE2-4EAC-8342-FF62C1D2A6EBQ46116703-6011B43F-2636-4A64-A5B7-78F213A4EA19Q46407476-E97B39E9-2FEB-4D9D-8EA4-9F5DAE1B9CD0Q46758390-8700F5CB-E575-40E1-9C0B-1CCE88E61765
P2860
Model systems to assess the destructive potential of human neutrophils and monocyte-derived macrophages during the acute and chronic phases of inflammation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Model systems to assess the de ...... hronic phases of inflammation.
@ast
Model systems to assess the de ...... hronic phases of inflammation.
@en
type
label
Model systems to assess the de ...... hronic phases of inflammation.
@ast
Model systems to assess the de ...... hronic phases of inflammation.
@en
prefLabel
Model systems to assess the de ...... hronic phases of inflammation.
@ast
Model systems to assess the de ...... hronic phases of inflammation.
@en
P2093
P2860
P1476
Model systems to assess the de ...... hronic phases of inflammation.
@en
P2093
P2860
P304
P356
10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
P577
2001-02-01T00:00:00Z